Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation With Bordetella Pertussis Using Controlled Human Infection

NCT06903221 is registered in ClinicalTrials.gov with Dimitri Diavatopoulos as lead sponsor.

NCT NCT06903221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06903221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation With Bordetella Pertussis Using Controlled Human Infection
Lead sponsor
Dimitri Diavatopoulos
Phase
Phase 4
Overall status
Active, not recruiting
Start date
October 16, 2024
Completion date
April 30, 2027
Enrollment
99 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pertussis infection, pertussis vaccines